Ohio Patent of the Month – April 2025
Great Lakes NeuroTechnologies has secured U.S. Patent No. 12,263,009 for its “Movement disorder continuous monitoring and therapy system,” a breakthrough in wearable health technology for Parkinson’s disease. This system enables continuous, real-world tracking of motor symptoms, potentially transforming patient care and clinical research.
Continuous Monitoring in Daily Life
Unlike traditional assessments that rely on periodic clinical visits, this patented system uses wearable sensors to collect movement data throughout a patient’s daily activities. Advanced algorithms distinguish between involuntary movements caused by Parkinson’s and normal voluntary actions, providing clinicians with accurate, real-time insights into symptom severity.
Enhancing Treatment and Research
The technology not only monitors symptoms but also integrates with treatment delivery systems, allowing for timely interventions based on the patient’s condition. By correlating movement data with clinical rating scales, it offers a standardized approach to evaluating disease progression and treatment efficacy. This continuous monitoring can capture the complex fluctuation patterns of Parkinson’s over extended periods, offering valuable data for both clinicians and researchers.
A Step Forward in Patient-Centered Care
This innovation reflects a growing trend toward personalized, home-based healthcare solutions. By facilitating remote monitoring and timely treatment adjustments, it aims to improve patient outcomes and quality of life. The system’s ability to provide detailed, objective data could also enhance the design and evaluation of clinical trials, potentially accelerating the development of new therapies.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
